Uudised

In 2022, teaching and studies continue according to the principles agreed upon at the beginning of the academic year.

According to a study recently published by University of Tartu researchers, the prevalence of chronic conditions and multimorbidity in Estonia is relatively high. The most frequent chronic condition is hypertension.

On Thursday, 4 November, Tartu will host Gustavus Adolphus Day celebrations to mark the 389th anniversary of the founding of the University of Tartu. The programme includes laying flowers on monuments, a book presentation, a concert and a film premiere.

Swedish King Gustavus Adolphus signed the foundation decree of Academia Dorpatensis (Academia Gustaviana) in 1632. The day dedicated to this event begins on 4 November at 15:20 with the laying of flowers on the monuments of Gustavus Adolphus and the University of Tartu’s first chancellor Johan Skytte.

The university aims to keep studies open as long as possible, which is why stronger safety measures are imposed.

Safe distancing should be maintained between people during classes, in public rooms and all, including those who are vaccinated, must wear masks in the university buildings. Only protective masks, not scarves or visors, may be used to cover the nose and mouth.

A study led by the University of Tartu shows that the prevalence of coronavirus among adults has increased at a moderate rate. Over the past month, the prevalence of coronavirus antibodies has remained unchanged. However, the number of people who have been in close contact with the infected has increased, and there are more and more people who do not change their everyday behaviour after close contact.

On 13 October, a new stage in the coronavirus prevalence study led by the University of Tartu started. It will give an overview of the prevalence of coronavirus and its antibodies in the adult population by 26 October.

Results of the most recent wave of the coronavirus prevalence study led by the University of Tartu indicate that about one per cent of the Estonian adult population is currently infected with coronavirus. At the same time, nearly 77% of adults have developed antibodies against coronavirus, either through vaccination or by recovering from the disease. Vaccinated people are almost three times less likely to get infected than those who have not been vaccinated or have not had the disease.

A new stage in the coronavirus prevalence study led by the University of Tartu researchers will start today. Based on the results of the study, an overview of the prevalence of coronavirus and antibodies to coronavirus in the adult population of Estonia will be given by 28 September.

To help promote vaccination in Tartu and Tartu County, on Saturday, the vaccination bus of Tartu University Hospital moves from Raatuse 22 to the city centre, next to Tartu Kaubamaja. On the bus, it is possible to get vaccinated from 10 to 16.

The recent stage of coronavirus prevalence study led by the University of Tartu confirms that vaccine protects against falling ill but a vaccinated person may still be a virus carrier. Because of a change in the sample, this stage of the study allows to draw reliable conclusions about vaccinated people only, and not about the entire adult population.

On 5 August, at the request of the Government of the Republic, researchers of the University of Tartu restart the study on the prevalence of coronavirus in Estonia. The study wave lasting until 16 August helps to get an overview of both the spread of the virus among the adult population as well as the development of antiviral immunity in society.

We'd like to start teaching and studies in the autumn as normally as possible and meet face to face in class, and therefore it is important that as many of our new and returning students and university staff as possible are vaccinated. The nearest vaccination locations can be found on the website vaktsineeri.ee.

The results of the last, recently ended stage of the coronavirus prevalence survey led by the University of Tartu show that the percentage of infectious adults in the population has decreased to 0.05%, while the proportion of adults with antibodies has grown to nearly 70%.